Fat Mass and Resistin: Predictive Factors For Anti-TNF Therapy Response In Ankylosing Spondylitis Patients

被引：0
|
作者：
Saad, Carla G. S. [1 ]
Abreu, Andressa Silva [1 ]
Medeiros Ribeiro, Ana Cristina [1 ]
Moraes, Julio C. B. [1 ]
Perandini, Luiz A. [1 ]
Dassouki, Thalita [1 ]
Pereira, Rosa M. R. [1 ]
Bonfa, Eloisa [1 ]
Pinto, Ana Lucia S. [1 ]
机构：
[1] Univ Sao Paulo, Fac Med, Sao Paulo, Brazil
来源：
ARTHRITIS AND RHEUMATISM | 2013年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2474
引用
收藏
页码：S1058 / S1058
页数：1
相关论文
共 50 条
  • [41] New treatment options in ankylosing spondylitis:: a role for anti-TNFα therapy
    Sieper, J
    Braun, J
    ANNALS OF THE RHEUMATIC DISEASES, 2001, 60 : III58 - III61
  • [42] A cost efficacy analysis on Anti-TNF therapy in ankylosing spondylitis.
    Singh, G
    Tandon, N
    Bala, M
    ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S613 - S613
  • [43] CIRCULATING MIR-145 AS A MARKER OF THERAPEUTIC RESPONSE IN PATIENTS WITH ANKYLOSING SPONDYLITIS RECEIVING ANTI-TNF THERAPY
    Prajzlerova, K.
    Hruskova, V.
    Komarc, M.
    Forejtova, S.
    Pavelka, K.
    Vencovsky, J.
    Senolt, L.
    Filkova, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : A48 - A48
  • [44] CLINICAL RESPONSE AND RADIOGRAPHIC PROGRESSION IN ANKYLOSING SPONDYLITIS PATIENTS UNDER ANTI-TNF THERAPY: IMPACT OF HIP INVOLVEMENT
    Shimabuco, A. Y.
    Milanez, F. M.
    Moraes, J. C. B.
    Perico, G. V.
    Goncalves, C. R.
    Waisberg, M. G.
    Sampaio-barros, P. D.
    Saad, C. G. S.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1292 - 1293
  • [45] The Role of CRP and Peripheral Disease in Achieving ASDAS Response to Anti-TNF Therapy in 397 Patients with Ankylosing Spondylitis
    Fagerli, Karen Minde
    Lie, Elisabeth
    van der Heijde, D. M. F. M.
    Heiberg, Marte S.
    Rodevand, Erik
    Kaufmann, Cecillie
    Mikkelsen, Knut
    Kalstad, Synnove
    Kvien, Tore K.
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S203 - S204
  • [46] Anti-TNFα therapy in ankylosing spondylitis -: A North West Side story
    Kaushik, VV
    Pillai, K
    Shaw, B
    Sykes, H
    Binymin, K
    RHEUMATOLOGY, 2005, 44 : I118 - I118
  • [47] IS IT POSSIBLE TO INTERRUPT ANTI-TNF THERAPY USING A TAPERING STRATEGY IN PATIENTS WITH ANKYLOSING SPONDYLITIS ACHIEVING CLINICAL RESPONSE?
    Navarro-Compan, V
    Plasencia, C.
    Monjo, I
    Peiteado, D.
    Villalba, A.
    Balsa, A.
    Martin-Mola, E.
    de Miguel, E.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2016, 34 (04) : 778 - 778
  • [48] LOW SCLEROSTIN LEVELS: A PREDICTIVE MARKER OF PERSISTENT INFLAMMATION IN ANKYLOSING SPONDYLITIS DURING ANTI-TNF THERAPY?
    Saad, C. G. S.
    Ribeiro, A. C. M.
    Moraes, J. C. B.
    Takayama, L.
    Goncalves, C. R.
    Rodrigues, M. B.
    de Oliveira, R. M.
    Silva, C. A.
    Bonfa, E.
    Pereira, R. M. R.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2012, 30 (04) : 607 - 607
  • [49] Superior outcomes for military ankylosing spondylitis patients treated with anti-TNF
    Rees, Jonathan D.
    Bennett, A. N.
    Harris, D.
    Jones, T.
    JOURNAL OF THE ROYAL ARMY MEDICAL CORPS, 2014, 160 (04) : 310 - 313
  • [50] The effect of anti-TNF agent on oxidation status in patients with ankylosing spondylitis
    Murat Karkucak
    Erhan Capkin
    Ahmet Alver
    Ayse Akyuz
    Abdulkadir Kiris
    Emel Ak
    Murat Topbas
    Mehmet Tosun
    Clinical Rheumatology, 2010, 29 : 303 - 307
12345